2nd patient with stable disease, page-109

This bit from the announcement sounds great. The strength of the last dose is to be in line with majority of antibodies treatments available on market. I can't stop thinking even though our dose will be same as others we may deliver outstanding results in this last group as our antibodies are natural so act much much better.

"Recruitment of this fourth group of three patients has commenced. These patients will initially receive four doses of PAT-SM6 at a dose level of 6 mg/kg, which is twice the amount received by the patients in the third cohort. This is more in line with dosing levels of other antibodies currently on the market."

NOW I definitely won't be able to sleep waiting for results...lol